The transthyretin-related protein: Structural investigation of a novel protein family

Journal of Structural Biology

Volumn 155, Issue 3, 2006, Pages 445-457

  Lundberg, Erik ^a   Bäckström, Stefan ^a   Sauer, Uwe H ^a   Sauer Eriksson, A Elisabeth ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Crystal structure; Escherichia coli; Transthyretin; Transthyretin related protein; TRP

Indexed keywords

BROMIDE; PREALBUMIN; TRANSTHYRETIN RELATED PROTEIN; UNCLASSIFIED DRUG; ZINC;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; HYDROGEN BOND; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; BINDING SITES; BROMIDES; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI PROTEINS; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PREALBUMIN; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID; ZINC COMPOUNDS;

ESCHERICHIA COLI;

EID: 33748788511     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2006.04.002     Document Type: Article

References (57)

1. Altland K., Winter P., Saraiva M.J., and Suhr O. Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin. Neurogenetics 5 (2004) 61-67
2. Altland K., Winter P., and Sauerborn M.K. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 20 (1999) 1349-1364
3. Ando Y., Ohlsson P.I., Suhr O., Nyhlin N., Yamashita T., Holmgren G., Danielsson A., Sandgren O., Uchino M., and Ando M. A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem. Biophys. Res. Commun. 228 (1996) 480-483
4. Benson M.D., and Uemichi T. Transthyretin amyloidosis. Amyloid: Int. J. Exp. Clin. Invest. 3 (1996) 44-56
5. Blake C.C., Geisow M.J., Oatley S.J., Rérat B., and Rérat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121 (1978) 339-356
6. Brünger A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355 (1992) 472-474
7. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54 (1998) 905-921
8. Collaborative Computational Project, N., 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, pp. 760-763.
9. Costa P.P., Figueira A.S., and Bravo F.R. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Natl. Acad. Sci. USA 75 (1978) 4499-4503
10. Czjzek M., Cicek M., Zamboni V., Burmeister W.P., Bevan D.R., Henrissat B., and Esen A. Crystal structure of a monocotyledon (maize ZMGlu1) beta-glucosidase and a model of its complex with p-nitrophenyl beta-d-thioglucoside. Biochem. J. 354 (2001) 37-46
11. DeLano W.L. The PyMOL Molecular Graphic System (2002), DeLano Scientific, San Carlos, CA, USA
12. Eneqvist T., Andersson K., Olofsson A., Lundgren E., and Sauer-Eriksson A.E. The β-slip: a novel concept in transthyretin amyloidosis. Mol. Cell 6 (2000) 1207-1218
13. Eneqvist T., Lundberg E., Karlsson A., Huang S., Santos C.R., Power D.M., and Sauer-Eriksson A.E. High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J. Biol. Chem. 279 (2004) 26411-26416
14. Eneqvist T., Lundberg E., Nilsson L., Abagyan R., and Sauer-Eriksson A.E. The transthyretin-related protein family. Eur. J. Biochem. 270 (2003) 518-532
15. Engh R.A., and Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. A 47 (1991) 392-400
16. Folli C., Pasquato N., Ramazzina I., Battistutta R., Zanotti G., and Berni R. Distinctive binding and structural properties of piscine transthyretin. FEBS Lett. 555 (2003) 279-284
17. Hamilton J.A., and Benson M.D. Transthyretin: a review from a structural perspective. Cell. Mol. Life Sci. 58 (2001) 1491-1521
18. Hamilton J.A., Steinrauf L.K., Braden B.C., Liepnieks J., Benson M.D., Holmgren G., Sandgren O., and Steen L. The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30→Met variant to 1.7-Å resolution. J. Biol. Chem. 268 (1993) 2416-2424
19. Harding M.M. Geometry of metal-ligand interactions in proteins. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 401-411
20. Higgins D.G., Thompson J.D., and Gibson T.J. Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 266 (1996) 383-402
21. Hornberg A., Eneqvist T., Olofsson A., Lundgren E., and Sauer-Eriksson A.E. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J. Mol. Biol. 302 (2000) 649-669
22. Hornberg A., Hultdin U.W., Olofsson A., and Sauer-Eriksson A.E. The effect of iodide and chloride on transthyretin structure and stability. Biochemistry 44 (2005) 9290-9299
23. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 (1991) 110-119
24. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26 (1993) 795-800
25. Kabsch W., and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 (1983) 2577-2637
26. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
27. Kishikawa M., Nakanishi T., Miyazaki A., Shimizu A., Nakazato M., Kangawa K., and Matsuo H. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum. J. Mass Spectrom. 31 (1996) 112-114
28. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24 (1991) 946-950
29. Lee Y., Lee do H., Kho C.W., Lee A.Y., Jang M., Cho S., Lee C.H., Lee J.S., Myung P.K., Park B.C., and Park S.G. Transthyretin-related proteins function to facilitate the hydrolysis of 5-hydroxyisourate, the end product of the uricase reaction. FEBS Lett. 579 (2005) 4769-4774
30. Li J. Brassinosteroid signaling: from receptor kinases to transcription factors. Curr. Opin. Plant Biol. 8 (2005) 526-531
31. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53 (1997) 240-255
32. Nam K.H., and Li J. The Arabidopsis transthyretin-like protein is a potential substrate of BRASSINOSTEROID-INSENSITIVE 1. Plant Cell 16 (2004) 2406-2417
33. Olofsson, A., Ippel, J.H., Wijmenga, S.S., Lundgren, E., Ohman, A., 2003. Probing solvent accessibility of transthyretin-amyloid by solution NMR spectroscopy. J. Biol. Chem.
34. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
35. Palha J.A. Transthyretin as a thyroid hormone carrier: function revisited. Clin. Chem. Lab. Med. 40 (2002) 1292-1300
36. Power D.M., Elias N.P., Richardson S.J., Mendes J., Soares C.M., and Santos C.R. Evolution of the thyroid hormone-binding protein, transthyretin. Gen. Comp. Endocrinol. 119 (2000) 241-255
37. Ramachandran G.N., and Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23 (1968) 283-438
38. Ramazzina I., Folli C., Secchi A., Berni R., and Percudani R. Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nat. Chem. Biol. 2 (2006) 144-148
39. Raychaudhuri A., and Tipton P.A. Cloning and expression of the gene for soybean hydroxyisourate hydrolase. Localization and implications for function and mechanism. Plant Physiol. 130 (2002) 2061-2068
40. Raychaudhuri A., and Tipton P.A. A familiar motif in a new context: the catalytic mechanism of hydroxyisourate hydrolase. Biochemistry 42 (2003) 6848-6852
41. Saraiva M.J. Transthyretin mutations in health and disease. Hum. Mutat. 5 (1995) 191-196
42. Saraiva M.J., Costa P.P., Birken S., and Goodman D.S. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans. Assoc. Am. Phys. 96 (1983) 261-270
43. Sauer U.H., and Ceska T.A. A simple method for making reproducible fibre loops for protein cryocrystallography. J. Appl. Crystallogr. 30 (1997) 71-72
44. Schomaker V., and Trueblood K.N. On the rigid-body motion of molecules in crystals. Acta Crystallogr. B 24 (1968) 63-76
45. Schultz A.C., Nygaard P., and Saxild H.H. Functional analysis of 14 genes that constitute the purine catabolic pathway in Bacillus subtilis and evidence for a novel regulon controlled by the PucR transcription activator. J. Bacteriol. 183 (2001) 3293-3302
46. Sebastião M.P., Saraiva M.J., and Damas A.M. The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273 (1998) 24715-24722
47. Serag A.A., Altenbach C., Gingery M., Hubbell W.L., and Yeates T.O. Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry 40 (2001) 9089-9096
48. Serpell L.C., Goldsteins G., Dacklin I., Lundgren E., and Blake C.C.F. The "edge strand" hypothesis: Prediction and test of a mutational "hot-spot" on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int. J. Exp. Clin. Invest. 3 (1996) 75-85
49. Suhr O.B., Ando Y., Ohlsson P.I., Olofsson A., Andersson K., Lundgren E., Ando M., and Holmgren G. Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Eur. J. Clin. Invest. 28 (1998) 687-692
50. Suhr O.B., Svendsen I.H., Ohlsson P.I., Lendoire J., Trigo P., Tashima K., Ranlov P.J., and Ando Y. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Amyloid: Int. J. Exp. Clin. Invest. 6 (1999) 187-191
51. Sunde M., Richardson S.J., Chang L., Pettersson T.M., Schreiber G., and Blake C.C. The crystal structure of transthyretin from chicken. Eur. J. Biochem. 236 (1996) 491-499
52. Takaoka Y., Ohta M., Miyakawa K., Nakamura O., Suzuki M., Takahashi K., Yamamura K., and Sakaki Y. Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met. Am. J. Pathol. 164 (2004) 337-345
53. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D. Biol. Crystallogr. 57 (2001) 122-133
54. Wojtczak A. Crystal structure of rat transthyretin at 2.5 Å resolution: first report on a unique tetrameric structure. Acta Biochim. Pol. 44 (1997) 505-517
55. Wojtczak A., Cody V., Luft J.R., and Pangborn W. Structures of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3′,5′-dinitro-N-acetyl-l-thyronine at 2.2 Å resolution. Acta Crystallogr. D 52 (1996) 758-765
56. Zhang Q., and Kelly J.W. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 42 (2003) 8756-8761
57. Zhang Q., and Kelly J.W. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in c10s/v30m transgenic mice?. Biochemistry 44 (2005) 9079-9085